Publication | Closed Access

Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors

Signaling PathwayMedicineTherapy ResponseReceptor Tyrosine KinasePotential BiomarkerGynecologyProgranulin ExpressionCell BiologyTumor SuppressorOncologyRadiation OncologyTumor BiologyEndocrine-related CancerOvarian Cancer